Profarma Apr2 T08 20080729 Eng

The document summarizes Profarma's earnings results for the second quarter of 2008. Key highlights include a 21.8% increase in gross revenue compared to the same period last year, reaching R$742.8 million. Adjusted EBITDA grew 21.6% to R$23.9 million. Profarma's market share reached 11.8%, up 1.1 percentage points from the prior year.